These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease. Roumie CL, Choma NN, Kaltenbach L, Mitchel EF, Arbogast PG, Griffin MR. Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402 [Abstract] [Full Text] [Related]
8. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. van der Linden MW, van der Bij S, Welsing P, Kuipers EJ, Herings RM. Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734 [Abstract] [Full Text] [Related]
9. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs. Castellsague J, Holick CN, Hoffman CC, Gimeno V, Stang MR, Perez-Gutthann S. Pharmacotherapy; 2009 Dec; 29(12):1397-407. PubMed ID: 19947799 [Abstract] [Full Text] [Related]
12. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT. Arch Intern Med; 2005 May 09; 165(9):978-84. PubMed ID: 15883235 [Abstract] [Full Text] [Related]
13. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S. Arthritis Res Ther; 2005 May 09; 7(2):R333-42. PubMed ID: 15743481 [Abstract] [Full Text] [Related]
14. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Schneeweiss S, Solomon DH, Wang PS, Rassen J, Brookhart MA. Arthritis Rheum; 2006 Nov 09; 54(11):3390-8. PubMed ID: 17075817 [Abstract] [Full Text] [Related]
15. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, Daugherty JR, Arbogast PG, García-Rodríguez LA. Circ Cardiovasc Qual Outcomes; 2009 May 09; 2(3):155-63. PubMed ID: 20031832 [Abstract] [Full Text] [Related]
16. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. García Rodríguez LA, Varas-Lorenzo C, Maguire A, González-Pérez A. Circulation; 2004 Jun 22; 109(24):3000-6. PubMed ID: 15197149 [Abstract] [Full Text] [Related]
17. Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect? Hudson M, Rahme E, Richard H, Pilote L. Arthritis Rheum; 2007 Apr 15; 57(3):516-23. PubMed ID: 17394181 [Abstract] [Full Text] [Related]
18. Antirheumatic drug use and the risk of acute myocardial infarction. Suissa S, Bernatsky S, Hudson M. Arthritis Rheum; 2006 Aug 15; 55(4):531-6. PubMed ID: 16874796 [Abstract] [Full Text] [Related]
19. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs. Spalding WM, Reeves MJ, Whelton A. Am J Ther; 2007 Aug 15; 14(1):3-12. PubMed ID: 17303969 [Abstract] [Full Text] [Related]
20. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Schneider V, Lévesque LE, Zhang B, Hutchinson T, Brophy JM. Am J Epidemiol; 2006 Nov 01; 164(9):881-9. PubMed ID: 17005625 [Abstract] [Full Text] [Related] Page: [Next] [New Search]